The function of Histocompatibility Complex (MHC) glycoproteins is to bind peptides derived from foreign antigens and display them on the cell surface for T-cell recognition. Unlike class I MHC molecules, which are involved in the recognition of cytoplasmic proteins, class II glycoproteins bind and display peptides derived predominantly from exogenous proteins. Experiments during the previous grant period suggest a model in which immature class II alphabeta dimers are prevented from binding peptides by a third glycoprotein, the Invariant (1) chain, which associates with them in the endoplasmic reticulum (ER). The I chain remains associated with class II molecules during intracellular transport until it is proteolytically degraded. This occurs in an endosomal compartment to which internalized antigens are directed, and to which class II alphabetaI complexes are transported following exit from the Golgi apparatus. Peptides derived from the internalized antigens are generated in this compartment and bind to the class II glycoproteins following I chain dissociation. In this proposal the molecular and cellular mechanisms which regulate this process will be investigated. The precise subunit structure of human class II (HLA-DR) complexes will be established. The molecular features of the I chain which a) allow it to prevent binding peptide by class II molecules, b) are responsible for its retention and trimerization in the ER in the absence of class II association, and c) are required for class II association, will be examined. The potential role of the I chain in directing class II molecules to the endosomal compartment will be evaluated. Human B-cell lines, expressing transfected genes encoding a membrane bound IgM specific for the trinitrophenyl (TNP) hapten, will be used to investigate the mechanisms involved in the internalization and degradation of protein antigens. Multivalent synthetic antigens with defined HLA-DR-binding peptides chemically coupled to carrier proteins will be used to follow the fate of an individual epitope from its internalization as part of a macromolecule, through proteolysis and association with class II molecules, to its expression on the cell surface for recognition by specific, HLA-DR-restricted, T-lymphocytes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023081-11
Application #
2062080
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1986-01-01
Project End
1996-01-31
Budget Start
1995-01-01
Budget End
1996-01-31
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Roche, Paul A; Cresswell, Peter (2011) Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 1991. 88: 3150-3154. J Immunol 187:1076-80
Wearsch, Pamela A; Cresswell, Peter (2008) The quality control of MHC class I peptide loading. Curr Opin Cell Biol 20:624-31
Sinnathamby, Gomathinayagam; Maric, Maja; Cresswell, Peter et al. (2004) Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin. J Immunol 172:6607-14
Ackerman, Anne L; Cresswell, Peter (2003) Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J Immunol 170:4178-88
Phan, Uyen T; Maric, Maja; Cresswell, Peter (2002) Disulfide reduction in major histocompatibility complex class II-restricted antigen processing by interferon-gamma-inducible lysosomal thiol reductase. Methods Enzymol 348:43-8
Kang, Suk-Jo; Cresswell, Peter (2002) Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 277:44838-44
Phan, Uyen T; Lackman, Rebecca L; Cresswell, Peter (2002) Role of the C-terminal propeptide in the activity and maturation of gamma -interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 99:12298-303
Maric, M; Arunachalam, B; Phan, U T et al. (2001) Defective antigen processing in GILT-free mice. Science 294:1361-5
Cannon, K S; Cresswell, P (2001) Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J 20:2443-53
Phan, U T; Maric, M; Dick, T P et al. (2001) Multiple species express thiol oxidoreductases related to GILT. Immunogenetics 53:342-6

Showing the most recent 10 out of 42 publications